# US 2010/0167404 A1 · Methods of Reprogramming Animal Somatic Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167404 A1
- Document ID: US20100167404A1
- Status: Published application
- Kind: A1
- Application number: 11/989,988
- Filed: 2006-08-03
- Published: 2010-07-01
- Earliest claimed: 2005-08-03
- Assignees: Advanced Cell Technology, Inc.
- Inventors: Michael D. West; Karen B. Chapman; Roy Geoffrey Sargent
- Web page: https://patentgrep.com/patent/US20100167404A1

## CPC

- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- A01K 67/0271: Chimeric vertebrates, e.g. comprising exogenous cells
- C12N 5/0676: {Pancreatic cells}
- C12N 5/16: Animal cells
- C12N 15/873: Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- C12N 2501/602: Sox-2
- C12N 2501/603: Oct-3/4
- C12N 2501/605: Nanog
- C12N 2501/606: c-Myc
- C12N 2501/72: Transferases [EC 2.]
- C12N 2506/00: Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N 2506/11: from blood or immune system cells
- C12Q 2600/158: Expression markers
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This invention generally relates to methods to obtain mammalian cells and tissues with patterns of gene expression similar to that of a developing mammalian embryo or fetus, and the use of such cells and tissues in the treatment of human disease and age-related conditions. More particularly, the invention relates to methods for identifying, expanding in culture, and formulating mammalian pluripotent stem cells and differentiated cells that differ from cells in the adult human in their pattern of gene expression, and therefore offer unique characteristics that provide novel therapeutic strategies in the treatment of degenerative disease.

## Claims

### Claim 1

A method for reprogramming an animal differentiated somatic cell to an undifferentiated stem cell, comprising the steps of:
(a) injecting one or more animal differentiated somatic cells into an oocyte, wherein said oocyte is from a species that is different from said somatic cell, and allowing the remodeling of the nucleus of said somatic cell, wherein said remodeling results in
(i) the remodeling of the nuclear envelope of the nucleus of said somatic cell, wherein one or more components of the nuclear envelope of said nucleus are removed and wherein one or more components from said oocyte are added to the nuclear envelope of said nucleus of said somatic cell, and
(ii) the reprogramming of the chromatin of said somatic cell resulting in the expression of genes of an undifferentiated cell, wherein said reprogramming of said chromatin comprises the removal of regulatory factors from said chromatin and the addition of regulatory factors from said oocyte to said chromatin; and
(b) transferring or fusing the resulting remodeled nucleus from step (a) into the enucleated cytoplasm of an undifferentiated embryonic cell to form an undifferentiated stem cell, and allowing the resulting undifferentiated stem cell to grow.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the step of:
(c) analyzing the karyotype of the resulting undifferentiated stem cells from step (b), and analyzing the gene expression pattern of said resulting undifferentiated stem cells to determine if said resulting undifferentiated stem cells display a pattern of gene expression expected of embryonic stem cells.

### Claim 3 (depends on 2)

The method of claim 2, wherein if said resulting cells do not display a gene expression pattern that is expected of embryonic stem cells, steps (a)-(c) are repeated one or more times until the gene expression pattern of the resulting cells from step (b) display a pattern of gene expression that is the pattern expected of embryonic stem cells.

### Claim 4 (depends on 1)

The method of claim 1, wherein the enucleated embryonic cell of step (b) is selected from the group consisting of enucleated blastomere cell, enucleated inner cell mass cell, enucleated oocyte, enucleated morula cell, enucleated ES cell, enucleated EG cell, and enucleated EC-derived cell.

### Claim 5 (depends on 1)

The method of claim 1, wherein at least two remodeled nuclei from step (a) are transferred or are fused with at least two enucleated cytoplasms in step (b).

### Claim 6 (depends on 1)

The method of claim 1, wherein said animal differentiated somatic cell is a human cell.

### Claim 7 (depends on 1)

The method of claim 1, wherein said oocyte is from the genus Xenopus.

### Claim 8 (depends on 1)

The method of claim 1, wherein said animal differentiated somatic cell is permeabilized prior to injection.

### Claim 9 (depends on 1)

The method of claim 1, wherein said oocyte expresses one or more factors selected from the group consisting of CROC4, DNMT3B, H2AFX, HIST1H2AB, HIST1H4J, HMGB2, LEFTB, MYBL2, MYC, MYCN, NANOG, OCT3/4 (POU5F1), OTX2, SALL4, SOX2, TERF1, TERT, ZNF206.

### Claim 10

A method for reprogramming an animal differentiated somatic cell to an undifferentiated stem cell, comprising the steps of:
(a) isolating the nucleus from one or more animal differentiated somatic cells and injecting said nucleus into an oocyte, wherein said oocyte is from a species that is different from the species of said somatic cell, and allowing the remodeling of the nucleus of said somatic cell, wherein said remodeling results in
(i) the remodeling of the nuclear envelope of said nucleus, wherein one or more components of the nuclear envelope of said nucleus are removed and wherein one or more components from said oocyte are added to the nuclear envelope of said nucleus of said somatic cell, and
(ii) the reprogramming of the chromatin of said somatic cell resulting in the expression of genes of an undifferentiated cell, wherein said reprogramming of said chromatin comprises the removal of regulatory factors from said chromatin and the addition of regulatory factors from said oocyte to said chromatin; and
(b) transferring or fusing the resulting remodeled nucleus from step (a) into the enucleated cytoplasm of an undifferentiated embryonic cell to form an undifferentiated stem cell, and allowing the resulting undifferentiated stem cell to grow.

### Claim 11 (depends on 10)

The method of claim 10, further comprising the step of (c) analyzing the karyotype of the resulting undifferentiated stem cells from step (b), and analyzing the gene expression pattern of said resulting undifferentiated stem cells to determine if said resulting undifferentiated stem cells display a pattern of gene expression expected of embryonic stem cells.

### Claim 12 (depends on 11)

The method of claim 11, wherein if said resulting cells do not display a gene expression pattern that is expected of embryonic stem cells, steps (a)-(c) are repeated one or more times until the gene expression pattern of the resulting cells from step (b) display a pattern of gene expression that is the pattern expected of embryonic stem cells.

### Claim 13 (depends on 10)

The method of claim 10, wherein at least two somatic cell nuclei are remodeled within one oocyte in step (a).

### Claim 14 (depends on 10)

The method of claim 10, wherein the enucleated embryonic cell of step (b) is selected from the group consisting of enucleated blastomere cell, enucleated inner cell mass cell, enucleated oocyte, enucleated morula cell, enucleated ES cell, enucleated EG cell, and enucleated EC-derived cell.

### Claim 15 (depends on 16)

The method of claim 16, wherein at least two remodeled nuclei from step (a) are transferred or are fused with at least two enucleated cytoplasms in step (b).

### Claim 16 (depends on 10)

The method of claim 10, wherein the differentiated somatic cell is human.

### Claim 17 (depends on 10)

The method of claim 10 wherein the oocyte is from the genus Xenopus.

### Claim 18 (depends on 10)

The method of claim 10 wherein said oocyte expresses one or more factors selected from the group consisting of CROC4, DNMT3B, H2AFX, HIST1H2AB, HIST1H4J, HMGB2, LEFTB, MYBL2, MYC, MYCN, NANOG, OCT3/4 (POU5F1), OTX2, SALL4, SOX2, TERF1, TERT, ZNF206.

### Claim 19 (depends on 10)

The method of claim 10, wherein the method further comprises the step of replacing one or more genes in the somatic cell genome by homologous recombination, wherein said homologous recombination comprises the addition of one or more DNA-targeting constructs and a protein or extract preparation proficient in homologous recombination, and wherein said step is performed before step (b).

### Claim 20 (depends on 19)

The method of claim 19, wherein said extract proficient in homologous recombination is an extract from the chicken pre-B cell line DT40 or the human lymphoid cell line DG75.

### Claim 21

A method for reprogramming an animal differentiated somatic cell to an undifferentiated stem cell, comprising the steps of:
(a) isolating the nucleus, DNA, or chromatin from said differentiated somatic cell and encapsulating said nucleus, DNA, or chromatin in a new nuclear envelope in vitro using extract from undifferentiated cells to form a remodeled nucleus; and
(b) transferring or fusing the resulting remodeled nucleus from step (a) into the enucleated cytoplasm of an undifferentiated embryonic cell to form an undifferentiated stem cell, and allowing the resulting undifferentiated stem cell to grow.

### Claim 22 (depends on 21)

The method of claim 21, further comprising the step of:
(c) analyzing the karyotype of the resulting undifferentiated stem cells from step (b), and analyzing the gene expression pattern of said resulting undifferentiated stem cells to determine if said resulting undifferentiated stem cells display a pattern of gene expression expected of embryonic stem cells.

### Claim 23 (depends on 22)

The method of claim 22, wherein if said resulting cells do not display a gene expression pattern that is expected of embryonic stem cells, steps (a)-(c) are repeated one or more times until the gene expression pattern of the resulting cells from step (b) display a pattern of gene expression that is the pattern expected of embryonic stem cells.

### Claim 24 (depends on 21)

The method of claim 21, wherein the enucleated embryonic cell of step (b) is selected from the group consisting of enucleated blastomere cell, enucleated inner cell mass cell, enucleated oocyte, enucleated morula cell, enucleated ES cell, enucleated EG cell, and enucleated EC-derived cell.

### Claim 25 (depends on 21)

The method of claim 21, wherein at least two remodeled nuclei from step (a) are transferred or are fused with at least two enucleated cytoplasms in step (b).

### Claim 26 (depends on 21)

The method of claim 21, wherein said animal differentiated somatic cell is a human cell.

### Claim 27 (depends on 21)

The method of claim 21, wherein the species from which the differentiated somatic cell and the undifferentiated cell extract originate are different.

### Claim 28 (depends on 21)

The method of claim 21, wherein the undifferentiated cell extract comprises one or more factors selected from the group consisting of CROC4, DNMT3B, H2AFX, HIST1H2AB, HIST1H4J, HMGB2, LEFTB, MYBL2, MYC, MYCN, NANOG, OCT3/4 (POU5F1), OTX2, SALL4, SOX2, TERF1, TERT, ZNF206.

### Claim 29 (depends on 21)

The method of claim 21, wherein the undifferentiated cell extract is from embryonic carcinoma cells.

### Claim 30 (depends on 21)

The method of claim 21, wherein the undifferentiated cell extract is an oocyte extract.

### Claim 31 (depends on 30)

The method of claim 30, wherein the oocyte extract is from oocytes of the genus Xenopus.

### Claim 32 (depends on 30)

The method of claim 30, wherein the oocyte extract is from oocytes of the genus Bos or Mus.

### Claim 33 (depends on 21)

The method of claim 21, wherein the method further comprises a step wherein the genome of the remodeled nucleus is modified by homologous recombination, wherein homologous recombination comprises the addition of one or more DNA-targeting constructs and a protein or extract preparation proficient in homologous recombination.

### Claim 34 (depends on 33)

The method of claim 33, wherein said homologous recombination results in the deletion or replacement of one or more genes.

### Claim 35 (depends on 33, 34)

The method of any of claims 33 and 34, wherein said protein or extract preparation proficient in homologous recombination is an extract from the chicken pre-B cell line DT40 or the human lymphoid cell line DG75.

### Claim 36 (depends on 21)

The method of claim 21, wherein step (a) further comprises condensing the somatic cell genome to a chromosome clump through the exposure of said somatic cell nuclei to an extract from mitotic cells.

### Claim 37 (depends on 36)

The method of claim 36, wherein said mitotic cells are selected from the group consisting of metaphase II oocytes and metaphase germ-line cells.

### Claim 38 (depends on 36)

The method of claim 36, wherein said mitotic cells are cells from a different species than the species of the differentiated somatic cell.

### Claim 39 (depends on 36)

The method of claim 36, wherein said extract from mitotic cells comprises one or more factors selected from the group consisting of CROC4, DNMT3B, H2AFX, HIST1H2AB, HIST1H4J, HMGB2, LEFTB, MYBL2, MYC, MYCN, NANOG, OCT3/4 (POU5F1), OTX2, SALL4, SOX2, TERF1, TERT, ZNF206.

### Claim 40

A method for reprogramming an animal differentiated somatic cell to an undifferentiated stem cell, comprising the steps of:
(a) isolating the nucleus from said differentiated somatic cell and condensing the chromatin to a chromosome clump through the exposure of said isolated nucleus to an extract from mitotic cells, thereby remodeling the somatic cell genome; and
(b) transferring or fusing the resulting remodeled genome from step (a) into the enucleated cytoplasm of an undifferentiated embryonic cell to form an undifferentiated stem cell, and allowing the resulting undifferentiated stem cell to grow.

### Claim 41 (depends on 40)

The method of claim 40, further comprising the step of:
(c) analyzing the karyotype of the resulting undifferentiated stem cells from step (b), and analyzing the gene expression pattern of said resulting undifferentiated stem cells to determine if said resulting undifferentiated stem cells display a pattern of gene expression expected of embryonic stem cells.

### Claim 42 (depends on 41)

The method of claim 41, wherein if said resulting cells do not display a gene expression pattern that is expected of embryonic stem cells, steps (a)-(c) are repeated one or more times until the gene expression pattern of the resulting cells from step (b) display a pattern of gene expression that is the pattern expected of embryonic stem cells.

### Claim 43 (depends on 40)

The method of claim 40, wherein said mitotic cells are cells from a different species than the species of the differentiated somatic cell.

### Claim 44 (depends on 40)

The method of claim 40, wherein said extract from mitotic cells comprises one or more factors selected from the group consisting of CROC4, DNMT3B, H2AFX, HIST1H2AB, HIST1H4J, HMGB2, LEFTB, MYBL2, MYC, MYCN, NANOG, OCT3/4 (POU5F1), OTX2, SALL4, SOX2, TERF1, TERT, ZNF206.

### Claim 45

A method for creating an undifferentiated animal cell of specific genetic identity, the method comprising the steps of:
(a) providing compositions of:
(i) a differentiated animal somatic cell, or nucleus or chromatin isolated therefrom, said differentiated animal somatic cell bearing a genetic identity desired for the undifferentiated animal cell to be created; and
(ii) an undifferentiated embryonic cell;
(b) performing chromatin or nuclear transfer with the compositions of step (a), wherein the composition of (a) (i) comprises the donor material and the composition of (a) (ii) comprises the recipient cell;
(c) isolating the nucleus resulting from the chromatin or nuclear transfer of step (b) from within the undifferentiated embryonic cell; and
(d) fusing the nucleus of step (c) with an enucleated cytoplasm of an embryonic stem cell to yield an undifferentiated animal cell of specific genetic identity.

### Claim 46

A method for reprogramming multiple animal somatic cells, the method comprising the steps of:
(a) providing:
(i) at least two differentiated animal somatic cells that have their nuclear envelope remodeled to that of an undifferentiated cell; and
(ii) at least two undifferentiated enucleated embryonic cell cytoplasts;
(b) performing nuclear transfer with the cells of step (a), wherein the remodeled animal somatic cell nuclei are transferred to the cytoplasts in (ii);
(c) isolating the nuclei resulting from the nuclear transfer of step (b) from within the Undifferentiated embryonic cell; and
(d) repeating steps (a)-(c) to yield multiple reprogrammed animal pluripotent stem cells.

### Claim 47

An assay to identify molecules useful to include or remove from a nucleus in the process of reprogramming to an undifferentiated state comprising the steps of:
(a) providing:
(i) an extract prepared from undifferentiated or germ-line cells, wherein said extract is capable of remodeling the nucleus of a differentiated cell and wherein said extract is modified by the addition or deletion a particular molecular component;
(ii) at least one differentiated animal somatic cell; and
(iii) at least one undifferentiated enucleated embryonic cell cytoplast;
(b) remodeling the nucleus of said somatic cell of (ii) with the extract of (i);
(c) performing nuclear transfer with the remodeled somatic cell nucleus of step (b), wherein the remodeled animal somatic cell nucleus is transferred to a recipient cytoplast;
(d) culturing cells resulting from step (c); and
(e) comparing the gene expression of said resulting cells of step (c) with normal embryonic cells of the same type as the cytoplast to determine whether the added or deleted molecular component plays a role in cellular reprogramming.

### Claim 48 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

A method of deriving differentiated cell types from the undifferentiated reprogrammed cells of any of claims 1-41, wherein said differentiated cells are obtained without the generation of an ES cell line, and wherein said method comprises the steps of:
(a) culturing said undifferentiated reprogrammed cells in the presence of at least one differentiation factor; and
(b) selecting differentiated cells from the culture of step (a), wherein said selection of differentiated cells comprises selecting cells that express one or more markers of a differentiated cell type.

### Claim 49 (depends on 48)

The method of claim 48 wherein said differentiated cells are pancreatic beta cells.

### Claim 50 (depends on 48)

The method of claim 48 wherein said differentiated cells are pancreatic precursor cells.

### Claim 51 (depends on 48)

The method of claim 48, wherein the method further comprises the step of permeabilizing said undifferentiated reprogrammed cells, wherein said permeabilization is performed prior to step (a).
